News

Catch up on the groundbreaking FDA approvals, key trial updates, and more news from the last month.

ABBV-CLS-628, an anti–PAPP-A monoclonal antibody, earns Orphan Drug Designation, advancing through phase 2 testing for ADPKD.

View slated expert interviews and 5 clinical trials to watch at AASLD The Liver Meeting 2025.

Stay up to date with the groundbreaking FDA decisions, critical trial updates, and more news from the last month.

Afzali details GALAXI post hoc findings on guselkumab in Crohn’s disease.

This month in review spotlights 6 top allergy stories, from falling peanut allergy rates to intranasal steroid cream easing post-surgical rhinosinusitis.

A multicenter study from NASPGHAN 2025 highlights geographic and immune-driven variations in pediatric H. pylori infection across the Americas.

Check out the latest GI FDA news, new trial data in IBD, headlines from ACG 2025, and more.

October brings FDA approvals, new KDIGO guidance, and diagnostic breakthroughs

Catch up with groundbreaking FDA decisions, exciting new GLP-1 news, and more.

Check out the latest episode of Liver Lineup on alcohol-associated liver disease, new data on resmetirom, hepatic headlines from ACG 2025, and more.

In this review of the month of October, HCPLive highlights some of the most significant dermatology news updates.

Alterations in appetite and weight may have influenced abdominal adiposity, as well as inflammatory and cardiometabolic markers.

Kwatra spoke at Fall Clinical about several key highlights from his sessions discussing atopic dermatitis, prurigo nodularis, and the OX40 ligand (OX40L).

The FDA has approved Kygevvi (doxycitine and doxribtimine), the first therapy to improve functional outcomes and survival in thymidine kinase 2 deficiency.

Following a Type A meeting with the FDA, the ophthalmic formulation of bevacizumab is back on track towards a potential US approval.

In his Fall Clinical interview, Chovatiya highlights several key takeaways from his talk on generalized pustular psoriasis (GPP) management.

Kidney Week 2025 showcases groundbreaking clinical trials and FDA approvals, marking a transformative era in nephrology and kidney disease treatment.

Susan Corbridge, PhD, and Alanna Kavannagh, MSN, CCRN, discuss the role of advanced practice providers on the evolving pulmonary and critical care teams during CHEST 2025.

Following CHEST 2025, Hanania discusses the progress being made toward more tailored, patient-oriented care in airway disorders.

Exposure to nonoptimal temperatures have shown an association with deaths among patients with heart failure.

These phase 4 data from the UnlIMMited trial highlight the efficacy and safety of risankizumab for psoriasis in the genital or scalp region.

Gabryszewski said new data confirm early introduction guidelines are working, showing real-world declines in peanut allergy.

Recent research has highlighted the influence of minor beat-to-beat changes in blood pressure on the left side of the brain.

Research reveals a significant skin-brain connection, linking inflammatory skin diseases to neurocognitive and emotional health, particularly in children with atopic dermatitis.

Meta-analysis finds peritoneal and hemodialysis offer similar survival in ESRD.

The interview highlights the evolution of atopic dermatitis treatment, emphasizing options beyond topical steroids.